BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Art Pappas to participate on panel, "Investing in Neurotech" at Neurotech Investing and Partnering Conference in Boston, MA
News | 05. 19. 2010
